Pathological complete response to neoadjuvant chemotherapy in triple negative breast cancer - single hospital experience.

Autor: Sivina E; Institute of Oncology, Tumour Clinical Research Department, Riga Stradins University, Riga, Latvia. elinasivina@inbox.lv.; Clinic of Oncology, Pauls Stradins Clinical University Hospital, Riga, Latvia. elinasivina@inbox.lv.; Department of Internal Diseases, Riga Stradins University, Riga, Latvia. elinasivina@inbox.lv., Blumberga L; Clinic of Oncology, Pauls Stradins Clinical University Hospital, Riga, Latvia., Purkalne G; Clinic of Oncology, Pauls Stradins Clinical University Hospital, Riga, Latvia.; Department of Internal Diseases, Riga Stradins University, Riga, Latvia., Irmejs A; Institute of Oncology, Tumour Clinical Research Department, Riga Stradins University, Riga, Latvia.; Breast Unit, Department of Surgery, Pauls Stradins Clinical University Hospital, Riga, Latvia.; Department of Surgery, Riga Stradins University, Riga, Latvia.

Publikováno v: Hereditary cancer in clinical practice [Hered Cancer Clin Pract] 2023 Mar 16; Vol. 21 (1), pp. 4. Date of Electronic Publication: 2023 Mar 16.

Recommendations for a Global Core Curriculum in Medical Oncology

Autor: Hansen, H.H. ^*, Bajorin, D.F., Muss, H.B., Purkalne, G., Schrijvers, D., Stahel, R.

Publikováno v: In Annals of Oncology November 2004 15(11):1603-1612

Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study.

Autor: Lindskog M; Department of Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala University, Uppsala, Sweden., Laurell A; Department of Oncology, Akademiska University Hospital, Uppsala, Sweden., Kjellman A; Department of Urology, CLINTEC, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden., Melichar B; Department of Urology and Urological Oncology, Wojewodzki Szpital Specjalistyczny im. Stefana Kardynała Wyszyńskiego, Lublin, Poland., Rey PM; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Zieliński H; Clinical Urology, Military Institute of Medicine, Warsaw, Poland., Villacampa F; Urology Service, Hospital Unversitario 12 Octubre, Madrid, Spain., Bigot P; Department of Urology, Centre Hospitalier Universitaire d'Angers, Angers Cedex, France., Zoltan B; Szent-Györgyi Albert Klinikai Központ, Szegedi Tudomanyegyetem Altalanos Ovostudomanyi Kar Urologiai Klinika, Szeged, Hungary., Parikh O; Rosemere Cancer Centre, Royal Preston Hospital, Preston, UK., Alba DV; Servicio de Urología, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain., Jellvert Å; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Flaskó T; Department of Urology, Medical School, University of Debrecen, Debrecen, Hungary., Gallardo E; Oncology Department, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Sabadell, Spain., Caparrós MJR; Department of Urology, Hospital Clínic Barcelona, Barcelona, Spain., Purkalne G; Oncology Clinic, Pauls Stradins Clinical University Hospital, Rīga, Latvia., Suenaert P; Immunicum AB, Stockholm, Sweden., Karlsson-Parra A; Immunicum AB, Stockholm, Sweden.; Department of Immunology, Genetics and Pathology, Section of Clinical Immunology, Uppsala University, Uppsala, Sweden., Ljungberg B; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.

Publikováno v: European urology open science [Eur Urol Open Sci] 2022 Apr 26; Vol. 40, pp. 38-45. Date of Electronic Publication: 2022 Apr 26 (Print Publication: 2022).

Ultrasound guided needle biopsy of axilla to evaluate nodal metastasis after preoperative systemic therapy in cohort of 106 breast cancers enriched with BRCA1/2 pathogenic variant carriers.

Autor: Līcīte B; Department of Surgery, Riga Stradiņš University, Pilsoņu iela 13, LV-1002, Riga, Latvia. baiba.licite@gmail.com.; Department of Surgery, (Affiliated Partner of the European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS)), Pauls Stradiņš Clinical University Hospital, Pilsoņu iela 13, LV-1002, Riga, Latvia. baiba.licite@gmail.com., Irmejs A; Department of Surgery, Riga Stradiņš University, Pilsoņu iela 13, LV-1002, Riga, Latvia.; Department of Surgery, (Affiliated Partner of the European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS)), Pauls Stradiņš Clinical University Hospital, Pilsoņu iela 13, LV-1002, Riga, Latvia.; Institute of Oncology, Riga Stradiņš University, Pilsoņu iela 13, LV-1002, Riga, Latvia., Maksimenko J; Department of Surgery, Riga Stradiņš University, Pilsoņu iela 13, LV-1002, Riga, Latvia.; Department of Surgery, (Affiliated Partner of the European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS)), Pauls Stradiņš Clinical University Hospital, Pilsoņu iela 13, LV-1002, Riga, Latvia.; Institute of Oncology, Riga Stradiņš University, Pilsoņu iela 13, LV-1002, Riga, Latvia., Loža P; Department of Surgery, Riga Stradiņš University, Pilsoņu iela 13, LV-1002, Riga, Latvia.; Department of Surgery, (Affiliated Partner of the European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS)), Pauls Stradiņš Clinical University Hospital, Pilsoņu iela 13, LV-1002, Riga, Latvia., Trofimovičs G; Department of Surgery, Riga Stradiņš University, Pilsoņu iela 13, LV-1002, Riga, Latvia.; Department of Surgery, (Affiliated Partner of the European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS)), Pauls Stradiņš Clinical University Hospital, Pilsoņu iela 13, LV-1002, Riga, Latvia., Miklaševičs E; Institute of Oncology, Riga Stradiņš University, Pilsoņu iela 13, LV-1002, Riga, Latvia., Nazarovs J; Department of Pathology, Pauls Stradiņš Clinical University Hospital, Pilsoņu iela 13, LV-1002, Riga, Latvia., Romanovska M; Department of Pathology, Pauls Stradiņš Clinical University Hospital, Pilsoņu iela 13, LV-1002, Riga, Latvia., Deičmane J; Department of Radiology, Pauls Stradiņš Clinical University Hospital, Pilsoņu iela 13, LV-1002, Riga, Latvia., Irmejs R; St John's College, University of Cambridge, Cambridge, England., Purkalne G; Department of Surgery, Riga Stradiņš University, Pilsoņu iela 13, LV-1002, Riga, Latvia.; Department of Oncology, Pauls Stradiņš Clinical University Hospital, Pilsoņu iela 13, LV-1002, Riga, Latvia., Gardovskis J; Department of Surgery, Riga Stradiņš University, Pilsoņu iela 13, LV-1002, Riga, Latvia.; Department of Surgery, (Affiliated Partner of the European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS)), Pauls Stradiņš Clinical University Hospital, Pilsoņu iela 13, LV-1002, Riga, Latvia.; Institute of Oncology, Riga Stradiņš University, Pilsoņu iela 13, LV-1002, Riga, Latvia.

Publikováno v: Hereditary cancer in clinical practice [Hered Cancer Clin Pract] 2021 Jul 07; Vol. 19 (1), pp. 30. Date of Electronic Publication: 2021 Jul 07.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.